Arcus Biosciences, Inc.
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 cl…
Biotechnology
US, Hayward [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Arcus Biosciences, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDArcus Biosciences, Inc. can't present revenue by segment